close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Are You Rotavirus-Ready?

The National Healthy Mothers, Healthy Babies Coalition Asks Parents, 'Are You Rotavirus-Ready?'

Nationwide Survey Shows Lack of Knowledge About Common and Potentially Serious Virus

ALEXANDRIA, Va., October 31, 2005 -- Many moms with young children are unfamiliar with rotavirus, according to a new nationwide survey conducted by the National Healthy Mothers, Healthy Babies Coalition (HMHB) to raise awareness about this unpredictable, highly contagious and potentially serious virus. Even though nearly all children are infected with rotavirus by the time they reach kindergarten, only about one in five mothers surveyed said that they are familiar with the virus, and more than two-thirds responded that they have heard little or nothing about it.

HMHB is teaming up with father and son renowned pediatricians and authors Drs. Bill and Jim Sears, with support from Merck & Co. Inc., to launch the new "Are You Rotavirus-Ready?" campaign to provide parents with information about rotavirus, including recognizing symptoms and the signs of dehydration. Rotavirus is the most common cause of severe dehydrating diarrhea in infants and young children and infects nearly all children by the age of three.

"Rotavirus is highly contagious and children can become infected at any time of year," said Jim Sears, M.D., pediatrician and co-author of "The Baby Book." "The virus is typically transmitted from person to person, through fecal-oral contact with contaminated hands and objects, so it is important for parents to pay close attention to their children all year long, but especially during the fall through the spring when cases peak in the United States."

Survey* Reveals Low Levels of Awareness

According to the survey of 600 mothers with children under age three conducted by HMHB, more than 70 percent of respondents said that they have heard little or nothing about rotavirus, and almost half (46 percent) said that they are not at all familiar with rotavirus. Of the respondents who said they are familiar with the virus (21 percent), nearly 60 percent did not know or think that it is the most common cause of diarrhea in young children, and almost half (49 percent) did not know or think that nearly all children will become infected with the virus by the time they enter kindergarten.

A majority of respondents, however, rated the potential symptoms of rotavirus as some of the most serious that could affect their child. Ninety- five percent of moms surveyed think that severe diarrhea is a serious or very serious symptom and more than nine out of 10 believe forceful vomiting with increased frequency is also a serious or very serious symptom.

"Given that rotavirus is so common and potentially serious, it is surprising that so few parents are aware of it," said Judy Meehan, Executive Director, HMHB. "Since there is no way to predict whether a child will have a mild or severe case, we want to help parents learn about rotavirus and its symptoms so they are prepared and know when to call their doctor."

Symptoms Can Be Serious

Symptoms of rotavirus vary but typically include fever, upset stomach, and vomiting, in conjunction with watery diarrhea. Children with rotavirus can have multiple episodes of diarrhea per day, and can last for three to nine days. Diarrhea, when combined with frequent vomiting, can lead to dehydration, or rarely, even death. Each year in the United States, rotavirus is responsible for an estimated:

  • 70,000 hospitalizations;
  • 160,000 emergency room visits among children younger than five -- an average of more than 3,000 visits per week;
  • 500,000 visits to doctor's offices; and
  • 100 deaths per year among children younger than five -- an average of nearly two deaths per week.

"For more than 30 years I've seen, and continue to see, cases of rotavirus -- both mild and severe -- that have affected children and their parents," said Bill Sears, M.D., pediatrician and co-author of "The Baby Book." "We know that nearly all children will get rotavirus and some of them will have symptoms that can quickly lead to severe dehydration. Through this campaign, we hope to educate parents about rotavirus and the risks of dehydration so they can identify the symptoms and be aware of the potential seriousness of the disease."

There are many different rotavirus strains and the prevalence of these strains varies by geography. While children can get rotavirus at any time of year, in the United States cases begin to peak in the fall. The number of rotavirus infections generally increases in the Southwest in November - January and spreads across the country in a wave, with infections typically peaking in the Northeast through the spring.

The National Healthy Mothers, Healthy Babies Coalition urges parents to familiarize themselves with the symptoms of rotavirus and know when cases of rotavirus tend to peak in their area.

For more information about "Are You Rotavirus-Ready?" and rotavirus, including a free brochure, consumers can visit www.rotavirusready.org.

About the National Healthy Mothers Healthy Babies Coalition

The National Healthy Mothers, Healthy Babies Coalition (HMHB) is a tax exempt, 501(c)(3) organization that reaches an estimated 10 million health care professionals, parents and policymakers through its membership of over 200 local, state and national organizations. Enhanced by a network of Healthy Mothers, Healthy Babies state and local coalitions across the country, HMHB promotes change and creates partnerships among community groups, nonprofit organizations, professional associations, businesses and government agencies. By promoting optimal health for mothers and children, HMHB works to strengthen families and build communities.

Source: National Healthy Mothers, Healthy Babies Coalition

* The national telephone survey was conducted with 600 mothers of children under the age of three, as children between six and 24 months of age are at greatest risk for severe disease. The margin of error at the 95% confidence level is +/- 4.0 percentage points.

Editor's Note: Merck & Co., Inc. submitted a Biologics License Application for Rotateq (rotavirus vaccine, live, oral, pentavalent) to the U.S. Food and Drug Administration (FDA) on April 5, 2005 . Rotateq is Merck's investigational vaccine to protect against rotavirus gastroenteritis. Rotateq is an oral, liquid vaccine that contains five human serotypes - G1, G2, G3, G4 and P1. These serotypes cause most rotavirus disease worldwide.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 24, 2008
Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare...
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...